Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Why IVUS Is Worth the Time and Cost
Video
Why IVUS Is Worth the Time and Cost
02/15/2022
Eric Secemsky, MD, presents data that show how the use of IVUS during peripheral artery and venous interventions has the potential to improve outcomes.
Eric Secemsky, MD, presents data that show how the use of IVUS during peripheral artery and venous interventions has the potential to improve outcomes.
Eric Secemsky, MD, presents data...
02/15/2022
Vascular Disease Management
Case Report
The Clinical Utility of the Zilver Vena Venous Self-Expanding Stent to Treat Symptomatic, Post-thrombotic Ileocaval Venous Obstruction
01/19/2022
The authors report their experience in treating patients with chronic venous disease using the Zilver Vena venous self-expanding stent.
The authors report their experience in treating patients with chronic venous disease using the Zilver Vena venous self-expanding stent.
The authors report their...
01/19/2022
Vascular Disease Management
What to Do With Chronic Filter-Related IVC Occlusion
Presentation
What to Do With Chronic Filter-Related IVC Occlusion
01/18/2022
In this presentation from ISET 2022, Dr. John Moriarty of the David Geffen School of Medicine at UCLA and University College in Dublin, Ireland, discusses the common clinical problem of chronic filter-related IVC occlusion and what to do when...
In this presentation from ISET 2022, Dr. John Moriarty of the David Geffen School of Medicine at UCLA and University College in Dublin, Ireland, discusses the common clinical problem of chronic filter-related IVC occlusion and what to do when...
In this presentation from ISET...
01/18/2022
Vascular Disease Management
Case Report
Use of Purse-String Suturing in Concordance With Surgical Excision for a Congenital Arteriovenous Malformation Over the Scalp
12/16/2021
Evaluation and management of an AVM over the scalp.
Evaluation and management of an AVM over the scalp.
Evaluation and management of an...
12/16/2021
Vascular Disease Management
Editor's Corner
Pelvic Congestion Syndrome: Often Undiagnosed and Misdiagnosed
11/18/2021
Read Dr. Walker's commentary on a case report by Turaga et al, which provides an excellent review of Nutcracker syndrome and the differential diagnosis of pelvic congestion syndrome.
Read Dr. Walker's commentary on a case report by Turaga et al, which provides an excellent review of Nutcracker syndrome and the differential diagnosis of pelvic congestion syndrome.
Read Dr. Walker's commentary on...
11/18/2021
Vascular Disease Management
Case Report
Nutcracker Syndrome: A Rare Etiology of Pelvic Congestion Syndrome
11/18/2021
A case of 34-year-old woman with pelvic congestion syndrome with nutcracker syndrome that was successfully treated.
A case of 34-year-old woman with pelvic congestion syndrome with nutcracker syndrome that was successfully treated.
A case of 34-year-old woman with...
11/18/2021
Vascular Disease Management
Original Research
Use of a Novel, Intermittent Pneumatic Compression Device to Promote Perforator Vein Dilation in Patients with Chronic Renal Failure: The pFACT Trial
10/20/2021
The Fist Assist Model FA-1
The Fist Assist Model FA-1
The Fist Assist Model FA-1
10/20/2021
Vascular Disease Management
Endovascular Technique
Controlled Step-Down Access Closure for Large Bore Access
08/19/2021
Guidewire-assisted controlled step-down technique allows for optimal hemostasis and dry field while maintaining continuous access to vascular lumen.
Guidewire-assisted controlled step-down technique allows for optimal hemostasis and dry field while maintaining continuous access to vascular lumen.
Guidewire-assisted controlled...
08/19/2021
Vascular Disease Management
Case Report
High-Output Heart Failure Caused by Femoral Arteriovenous Fistula 27 Years After Trauma
04/19/2021
A 67-year-old woman who had been caught in a cultivator and had her right leg amputated in the 1980s. She had no medical history of congestive heart failure or shortness of breath.
A 67-year-old woman who had been caught in a cultivator and had her right leg amputated in the 1980s. She had no medical history of congestive heart failure or shortness of breath.
A 67-year-old woman who had been...
04/19/2021
Vascular Disease Management
Original Research
Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound
03/04/2021
More than 80 million Americans suffer from chronic venous disease, which often is visually recognized as varicose veins. If left untreated, these abnormal leg veins can progressively worsen and cause other complications.
More than 80 million Americans suffer from chronic venous disease, which often is visually recognized as varicose veins. If left untreated, these abnormal leg veins can progressively worsen and cause other complications.
More than 80 million Americans...
03/04/2021
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement